V. Gerloni

7.5k total citations
70 papers, 2.3k citations indexed

About

V. Gerloni is a scholar working on Hematology, Rheumatology and Speech and Hearing. According to data from OpenAlex, V. Gerloni has authored 70 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Hematology, 34 papers in Rheumatology and 19 papers in Speech and Hearing. Recurrent topics in V. Gerloni's work include Autoimmune and Inflammatory Disorders Research (52 papers), Adolescent and Pediatric Healthcare (19 papers) and Rheumatoid Arthritis Research and Therapies (15 papers). V. Gerloni is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (52 papers), Adolescent and Pediatric Healthcare (19 papers) and Rheumatoid Arthritis Research and Therapies (15 papers). V. Gerloni collaborates with scholars based in Italy, United States and Netherlands. V. Gerloni's co-authors include F Fantini, M. Gattinara, Irene Pontikaki, Elisabetta Miserocchi, Rolando Cimaz, Pier Luigi Meroni, Francesco Zulian, Giulio Modorati, Giorgia Martini and Kaisu Kotaniemi and has published in prestigious journals such as Annals of the Rheumatic Diseases, Journal of the American Academy of Dermatology and Investigative Ophthalmology & Visual Science.

In The Last Decade

V. Gerloni

70 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Gerloni Italy 29 1.3k 934 556 515 402 70 2.3k
Syuji Takei Japan 26 1.2k 0.9× 1.2k 1.2× 196 0.4× 360 0.7× 456 1.1× 108 2.7k
Ivan Foeldvari Germany 34 1.6k 1.2× 952 1.0× 409 0.7× 676 1.3× 519 1.3× 178 3.6k
Joseph E. Levinson United States 25 1.5k 1.1× 1.0k 1.1× 179 0.3× 707 1.4× 361 0.9× 50 2.6k
Xiao-hu He China 3 2.6k 2.0× 1.1k 1.1× 246 0.4× 1.0k 2.0× 666 1.7× 7 3.2k
José Goldenberg Brazil 4 2.7k 2.0× 1.1k 1.1× 251 0.5× 1.0k 2.0× 696 1.7× 8 3.2k
F Fantini Italy 23 767 0.6× 574 0.6× 112 0.2× 291 0.6× 297 0.7× 69 1.6k
Javier Orozco-Alcalá Mexico 8 3.4k 2.5× 1.4k 1.5× 307 0.6× 1.3k 2.5× 831 2.1× 11 4.2k
Loredana Lepore Italy 23 598 0.4× 462 0.5× 201 0.4× 152 0.3× 272 0.7× 76 1.6k
Bianca Lang Canada 26 602 0.4× 817 0.9× 78 0.1× 270 0.5× 434 1.1× 79 2.2k
Rotraud K. Saurenmann Switzerland 22 1.3k 0.9× 1.0k 1.1× 566 1.0× 220 0.4× 217 0.5× 40 1.8k

Countries citing papers authored by V. Gerloni

Since Specialization
Citations

This map shows the geographic impact of V. Gerloni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Gerloni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Gerloni more than expected).

Fields of papers citing papers by V. Gerloni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Gerloni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Gerloni. The network helps show where V. Gerloni may publish in the future.

Co-authorship network of co-authors of V. Gerloni

This figure shows the co-authorship network connecting the top 25 collaborators of V. Gerloni. A scholar is included among the top collaborators of V. Gerloni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Gerloni. V. Gerloni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ruperto, Nicolino, Hermine I. Brunner, Nikolay Tzaribachev, et al.. (2021). Absence of Association Between Abatacept Exposure and Initial Infection in Patients With Juvenile Idiopathic Arthritis. The Journal of Rheumatology. 48(7). 1073–1081. 4 indexed citations
2.
Poddighe, Dimitri, Micol Romano, M. Gattinara, & V. Gerloni. (2018). Biologics for the Treatment of Juvenile Idiopathic Arthritis. Current Medicinal Chemistry. 25(42). 5860–5893. 31 indexed citations
3.
Lucia, Orazio De, Viviana Ravagnani, Francesca Pregnolato, et al.. (2018). Baseline ultrasound examination as possible predictor of relapse in patients affected by juvenile idiopathic arthritis (JIA). Annals of the Rheumatic Diseases. 77(10). 1426–1431. 42 indexed citations
4.
Tappeiner, Christoph, Elisabetta Miserocchi, Bahram Bodaghi, et al.. (2015). Abatacept in the Treatment of Severe, Longstanding, and Refractory Uveitis Associated with Juvenile Idiopathic Arthritis. The Journal of Rheumatology. 42(4). 706–711. 56 indexed citations
5.
Romano, Micol, Irene Pontikaki, M. Gattinara, et al.. (2014). Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients. Reumatismo. 65(6). 278–278. 16 indexed citations
6.
Mannurita, Sara Ciullini, Marina Vignoli, Lucia Bianchi, et al.. (2013). CACP syndrome: identification of five novel mutations and of the first case of UPD in the largest European cohort. European Journal of Human Genetics. 22(2). 197–201. 28 indexed citations
7.
Miserocchi, Elisabetta, Giulio Modorati, Irene Pontikaki, Pier Luigi Meroni, & V. Gerloni. (2013). Long-term Treatment with Golimumab for Severe Uveitis. Ocular Immunology and Inflammation. 22(2). 90–95. 66 indexed citations
8.
Kimura, Yukiko, Jennifer E. Weiss, Tzielan Lee, et al.. (2012). Pulmonary Hypertension and Other Potentially Fatal Pulmonary Complications in Systemic Juvenile Idiopathic Arthritis. Arthritis Care & Research. 65(5). 745–752. 102 indexed citations
9.
Gerloni, V., et al.. (2011). Temporomandibular joint involvement in juvenile idiopathic arthritis: treatment with an orthodontic appliance. Reumatismo. 57(3). 201–7. 12 indexed citations
10.
11.
12.
Miserocchi, Elisabetta, Irene Pontikaki, Giulio Modorati, et al.. (2011). Anti-CD 20 monoclonal antibody (rituximab) treatment for inflammatory ocular diseases. Autoimmunity Reviews. 11(1). 35–39. 61 indexed citations
13.
Zulian, Francesco, Giorgia Martini, Cristina Vallongo, et al.. (2011). Methotrexate treatment in juvenile localized scleroderma: A randomized, double-blind, placebo-controlled trial. Arthritis & Rheumatism. 63(7). 1998–2006. 142 indexed citations
14.
Vastert, Sebastiaan J., V. Gerloni, Irene Pontikaki, et al.. (2011). Development of Inflammatory Bowel Disease in Patients with Juvenile Idiopathic Arthritis Treated with Etanercept. The Journal of Rheumatology. 38(7). 1441–1446. 57 indexed citations
15.
Céspedes-Cruz, Adriana Ivonne, Raúl Gutiérrez-Suárez, Angela Pistorio, et al.. (2007). Methotrexate improves the health-related quality of life of children with juvenile idiopathic arthritis. Annals of the Rheumatic Diseases. 67(3). 309–314. 37 indexed citations
16.
Cimaz, Rolando, Marie-Angélique Cazalis, C. Reynaud, et al.. (2007). IL1 and TNF gene polymorphisms in patients with juvenile idiopathic arthritis treated with TNF inhibitors. Annals of the Rheumatic Diseases. 66(7). 900–904. 37 indexed citations
17.
Gregorio, Andrea, Claudio Gambini, V. Gerloni, et al.. (2006). Lymphoid neogenesis in juvenile idiopathic arthritis correlates with ANA positivity and plasma cells infiltration. Lara D. Veeken. 46(2). 308–313. 58 indexed citations
18.
Fantini, F, et al.. (2003). Remission in juvenile chronic arthritis: a cohort study of 683 consecutive cases with a mean 10 year followup.. PubMed. 30(3). 579–84. 111 indexed citations
19.
Ravelli, Angelo, Carolina Duarte‐Salazar, Silvia Buratti, et al.. (2003). Assessment of damage in juvenile‐onset systemic lupus erythematosus: A multicenter cohort study. Arthritis Care & Research. 49(4). 501–507. 118 indexed citations
20.
Gattorno, Marco, V. Gerloni, Antonella Buoncompagni, et al.. (2002). Synovial membrane expression of matrix metalloproteinases and tissue inhibitor 1 in juvenile idiopathic arthritides.. PubMed. 29(8). 1774–9. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Syuji Takei Breakdown of academic impact, for papers by Ivan Foeldvari Breakdown of academic impact, for papers by Joseph E. Levinson Breakdown of academic impact, for papers by Xiao-hu He Breakdown of academic impact, for papers by José Goldenberg Breakdown of academic impact, for papers by F Fantini Breakdown of academic impact, for papers by Javier Orozco-Alcalá Breakdown of academic impact, for papers by Loredana Lepore Breakdown of academic impact, for papers by Bianca Lang Breakdown of academic impact, for papers by Rotraud K. Saurenmann
Rankless by CCL
2026